Despite the ongoing war in the Ukraine and the Corona pandemic, Veyx-Pharma keeps its investment plans. Parts of those plans were fulfilled with a new laboratory, which is now operating in Schwarzenborn/Knüll in Hesse.
“The old laboratory became too small. The new 300-square-foot-building will strengthen our development capacities”, says managing director Dr. Silke Engl. “It is also an acknowledgement of our location and expresses the will to act long-term on the market”.
The Veyx-laboratory ensures and controls the quality of veterinary pharmaceuticals, complementary feeds, complementary feeds with particular nutritional purposes and animal care products. It is also important to the areas of science and development. The laboratory is GMP-certified (Standard of Good Manufacturing Practice)
The middle-sized company was founded in 1984 and grew into an internationally acting group. Today, Veyx-Pharma exports products into over 60 countries. The managing directors are company founder Armin Heß and his daughter Dr. Silke Engl.
